The accomplishment gene: SanoGene Therapeutics CEO also looks at deals for local venture capital firm
News posting on May 19, 2008 | Related to crowdSpring
Caralynn Nowinski knows how to multitask. When the 30-year-old Palos Park native is not reviewing investment opportunities for Midwest Venture Partners, she runs a biotechnology start-up focused on combatting the deadly effects of brain cancer.
Source: Chicago Sun-Times
